ZAP Surgical Systems, Inc.

Leveraging unique gyroscopic motion, ZAP-X® opens new frontiers in modern radiosurgery. Combining self-shielding technology with high dose rate linear-accelerator delivery, ZAP-X was created to safely treat more patients in more places.

https://zapsurgical.com

51-200 employees

Growth Trajectory

ZAP Surgical is focused on expanding its global footprint by installing ZAP-X systems in more hospitals and outpatient centers, particularly in underserved communities and countries with regulatory hurdles. With recent Series E funding, the company plans to accelerate manufacturing, sales, and distribution of its ZAP-X platform, while also investing in better technology and new clinical applications. Installations in multiple countries and regulatory approvals signal strong market expansion potential.

Technical Challenges

Tech Stack

Team Size

Key Risks

Competition from established radiotherapy systems like CyberKnife and other SRS technologies could limit market share.

Regulatory hurdles and varying shielding requirements in different countries might delay market entry and increase costs.

Potential intellectual property disputes, such as the IP suit with Elekta, could disrupt operations and impact market position.

Market acceptance and adoption of the ZAP-X system may be hindered by the perceived effectiveness of existing SRS technologies.

Tightening regulations regarding live radioactive Co-60 sources could impact the competitive landscape but might also create an advantage for ZAP Surgical's Cobalt-free LINAC system.

Opportunities

Leverage the ZAP-X system's self-shielding design to penetrate markets where traditional radiotherapy bunkers are cost-prohibitive or impractical.

Expand partnerships with hospitals and medical centers to establish ZAP-X installation sites and build a distinguished clinical brand.

Capitalize on the increasing demand for non-invasive brain tumor treatments by promoting the ZAP-X platform's precision and reduced side effects.

Continue innovating in gyroscopic radiosurgery and Dynamic Spherical Delivery (DSD) to enhance treatment quality and reduce treatment time.

Target outpatient centers and satellite hospitals to broaden access to SRS in suburban and rural communities.

Live Data Stream

Access Our Live VC Funding Database

30,000+ funded startups

tracked in the last 3 months

B2B verified emails

of key decision makers

Growth metrics

Real-time company performance data

Live updates

of new VC funding rounds

Advanced filters

for sophisticated queries

API access

with multiple export formats

Access Database

Updated every 5 minutes